Zydus Lifesciences Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For ZYDUSLIFE, that strike is ₹1,160. Spot at ₹1,175.5 is 1.34% above max pain — possible downward gravitational pull into expiry.
Max Pain Level
The calculated max‑pain strike for ZYDUSLIFE sits at ₹1160, the level where option writers would experience the smallest aggregate loss if all contracts expired worthless. As the expiry date of 23 November 2026 approaches, this strike often acts like a magnet, pulling the underlying price toward it in the short term.
Spot vs Max Pain Gap
The current spot price of ₹1175.5 sits about 1.34 % above the max‑pain level, indicating a modest premium over the theoretical loss‑minimizing point. If the market continues to pull back toward ₹1160, the gap could narrow, potentially easing pressure on call writers while increasing exposure for put writers.
Shift Signal
The max‑pain figure shifted lower by ₹10 since yesterday, a more downward move that suggests option writers are readjusting their hedges toward a softer price target. Such a shift typically signals that the majority of open interest is positioned to benefit if the underlying drifts lower, reinforcing the bearish bias of the writer side.
Expiry Context
Max‑pain theory generally posits that, as expiration nears, the price gravitates toward the strike that minimizes total writer loss, though market forces can override this tendency. During the final week before expiry, traders often see heightened volatility as positions are closed, making the ₹1160 level a focal point but not a guaranteed outcome for traders.
Data Note
The spot sits ₹15.5 above max pain with approximately 26 days remaining until expiration.
Data as of 2026-10-28